COsegregation of VARiants in Panel of Genes
The aim of the COVAR project is to achieve reliable classification of as many variants of interest as possible from the French OncoGenetics Database (FrOG, https://frog-db.fr/) in order to use them for the genetic counseling. The results obtained through this study will have a major impact on clinical management of the patients and their families conducting in some cases to propose a prophylactic surgery.
Conditions studied
Gene Mutation-Related Cancer, Genetic Predisposition
About this study
The aim of the COVAR project is to achieve reliable classification of as many variants of interest as possible from the French OncoGenetics Database (FrOG, https://frog-db.fr/) in order to use them for the genetic counseling. The results obtained through this study will have a major impact on clinical management of the patients and their families conducting in some cases to propose a prophylactic surgery.
Interventions
- Genetic: salivary kit — The saliva samples will be made of selected related (DNA).
Primary outcomes
- Perform the co-segregation analysis of the selected VUS (class 3) or likely pathogenic variant (class 4) in the families. (up to 15 years)
Eligibility information
Study locations
- Centre Hospitalier de Bastia, Bastia, Corsica 20604 France
- Institut Curie - Saint-Cloud site, Saint-Cloud, Haut de Seine 92210 France
- CHU Amiens - Hôpital Nord, Amiens, 80054 France
- ICO - Centre Paul Papin, Angers, 49933 France
- Centre Hospitalier d'Angoulème, Angoulême, 16959 France
- Institut Sainte-Catherine, Avignon, 84918 France
- CHU Besançon, Besançon, 25030 France
- Groupe Hospitalier Pellegrin, Bordeaux, 33076 France
- Institut Bergonié, Bordeaux, 33076 France
- Centre Hospitalier Jacques Coeur, Bourges, 18020 France
Showing 10 of 62 reported sites. See the official listing for all locations.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-29.